Skip Navigation

Cardiovascular Research 1998 40(2):282-289; doi:10.1016/S0008-6363(98)00185-0
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Penny, D. J
Right arrow Articles by Smolich, J. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penny, D. J
Right arrow Articles by Smolich, J. J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Increased aortic blood pressure contributes to potentiated dobutamine inotropic responses after systemic NO synthase inhibition in sheep

Daniel J Pennya,b,c, Hong Chenb and Joseph J Smolicha,b,*

aInstitute of Reproduction and Development, Monash University, Clayton, Victoria, Australia
bCentre for Heart and Chest Research, Monash University, Clayton, Victoria, Australia
cDepartment of Cardiology, Royal Children's Hospital, Melbourne, Australia

* Corresponding author. Tel.: +61-3-9550-5470; Fax: +61-3-9550-5554; E-mail: joe.smolich@med.monash.edu.au

Objective: To determine whether inotropic responses to the β-adrenergic agonist dobutamine are potentiated by systemic inhibition of nitric oxide synthase (NOS) with the L-arginine analogue N{omega}-nitro-L-arginine (L-NNA), and to establish to what extent any observed responses are related to the increase in aortic blood pressure accompanying systemic NOS inhibition. Methods: Dobutamine was infused incrementally at rates of 1, 2.5, 5 and 10 µg/kg/min in 15 open-chest, anaesthetised ewes before and after inhibition of NO synthesis with i.v. L-NNA (n=8), or elevation of mean aortic blood pressure to the same extent as attained with NOS inhibition using proximal arterial occlusion (n=7). Results: By the peak infusion rate, dobutamine increased the maximal rate of rise of left ventricular pressure (LV dP/dtMAX) by 100% (p<0.001) and reduced LV stroke work by 18% (p<0.01). L-NNA and arterial occlusion increased resting mean aortic blood pressure by 55±4 and 51±3 mmHg respectively. Compared to dobutamine alone, subsequent peak dobutamine-related increases in LV dP/dtMAX were augmented by 76% after L-NNA and by 88% after arterial occlusion (both p<0.001). Moreover, dobutamine increased LV stroke work by 23% at infusion rates of 1–5 µg/kg/min (p<0.001) after L-NNA, and by 17% at an infusion rate of 1 µg/kg/min (p<0.01) after arterial occlusion. Conclusions: Systemic NOS inhibition potentiates the effects of dobutamine on LV isovolumic and pumping performance in the intact circulation, but this potentiation is in large part related to the increase in arterial blood pressure accompanying NOS inhibition.

KEYWORDS Nitric oxide; Ventricular function; Inotropic agents; Adrenergic agents; Blood pressure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.